"The RWJBarnabas Health Advanced Lung Diseases and Transplant Program at Newark Beth Israel Medical Center (NBIMC) offers increased access to single and double lung transplant and comprehensive treatment and management of chronic and complex lung disease."

During the past decade, Barnabas Health Lung Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Barnabas Health Lung Center" are "Heart Failure With Preserved Ejection Fraction" (1 trials), "Pulmonary Hypertension" (1 trials) and "Pulmonary Hypertension Associated With HFpEF" (1 trials). Many other conditions were trialed in "Barnabas Health Lung Center" in a lesser frequency.

Most popular intervention types in "Barnabas Health Lung Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Oral treprostinil" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Barnabas Health Lung Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Barnabas Health Lung Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Barnabas Health Lung Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Barnabas Health Lung Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".